Clinical commissioning policy: Subcutaneous copper histidinate injections for presymptomatic neonates with classical Menkes disease

Document first published:
Page updated:
Topic:
Publication type:

Subcutaneous copper histidinate is recommended to be available as a routine commissioning treatment option for presymptomatic neonates with classical Menkes disease within the criteria set out in this document.